Johnson & Johnson

Johnson & Johnson (J&J) (NYSE: JNJ) is one of the largest healthcare companies in the world. J&J manufactures pharmaceutical products, provides healthcare expertise, and designs productive healthcare technologies. During FY2023, J&J generated revenue of USD 85.2 billion. In August 2023, J&J spun off Kenvue, its rebranded Consumer Health segment, as a separate company. However, J&J continued to hold a stake of 9.5% in Kenvue.

J&J’s operations are categorized under two main segments: Innovative Medicine (formerly Pharmaceutical) and MedTech, contributing 64% and 36% of total revenue, respectively. The Innovative Medicine segment offers products for diverse therapeutic areas, including immunology, oncology, and cardiovascular and metabolism, while the MedTech division focuses on products for orthopedics, interventional solutions, surgery, and vision categories. 

The US is J&J’s largest market, accounting for 55% of total revenue in FY2023, followed by Europe (24%), the APAC and African regions (16%), and the Western Hemisphere (5%). J&J expects to reach carbon neutrality in its global operations by 2030.